ES2150986T3 - Proteina y peptidos alergenicos de los acaros del polvo domestico y aplicaciones para los mismos. - Google Patents

Proteina y peptidos alergenicos de los acaros del polvo domestico y aplicaciones para los mismos.

Info

Publication number
ES2150986T3
ES2150986T3 ES94910283T ES94910283T ES2150986T3 ES 2150986 T3 ES2150986 T3 ES 2150986T3 ES 94910283 T ES94910283 T ES 94910283T ES 94910283 T ES94910283 T ES 94910283T ES 2150986 T3 ES2150986 T3 ES 2150986T3
Authority
ES
Spain
Prior art keywords
der
vii
activity
peptides
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94910283T
Other languages
English (en)
Inventor
Wayne Robert Thomas
Kaw-Yan Chua
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Telethon Kids Institute TVW
Original Assignee
Telethon Kids Institute TVW
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Telethon Kids Institute TVW filed Critical Telethon Kids Institute TVW
Application granted granted Critical
Publication of ES2150986T3 publication Critical patent/ES2150986T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/7051T-cell receptor (TcR)-CD3 complex
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/24Immunology or allergic disorders
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Insects & Arthropods (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)

Abstract

ACIDOS NUCLEICOS AISLADOS QUE CODIFICAN ALERGENOS DE LA ESPECIE DERMATOPHAGOIDES PTERONYSSINUS Y DERMATOPHAGOIDES FARINAE, DER P VII Y DER F VII, RESPECTIVAMENTE. UNA CDNA QUE CODIFICA UN PEPTIDO CON UNA ACTIVIDAD DER P VII Y UN PESO MOLECULAR PREDECIDO DE APROXIAMDAMENTE 22,177 DALTONES. UN CDNA QUE CODIFICA UN PEPTIDO CON UNA ACTIVIDAD DER F VII. LOS ACIDOS NUCLEICOS DEL INVENTO PUEDEN SER UTILIZADOS COMO PRUEBAS PARA DETECTAR LA PRESENCIA ACIDONUCLEICO DER F VII O DER P VII, EN UNA MUESTRA O PARA LA PRODUCCION RECOMBINANTE DE PEPTIDOS CON UNA ACTIVIDAD DER F VII O DER P VII. LOS PEPTIDOS CON UNA ACTIVIDAD DER F VII O DER P VII PUEDEN SER UTILIZADOS EN COMPOSICIONES APROPIADAS PARA LA ADMINISTRACION FARMACEUTICA O METODOS PARA DIAGNOSTICAR ALERGIAS SENSIBLES A LAS MOTAS DE POLVO DOMESTICO.
ES94910283T 1993-03-12 1994-03-11 Proteina y peptidos alergenicos de los acaros del polvo domestico y aplicaciones para los mismos. Expired - Lifetime ES2150986T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3114193A 1993-03-12 1993-03-12
US08/081,540 US6849427B1 (en) 1993-03-12 1993-06-22 Nucleic acids encoding a house dust mite allergen, Der p VII, and uses therefor

Publications (1)

Publication Number Publication Date
ES2150986T3 true ES2150986T3 (es) 2000-12-16

Family

ID=26706883

Family Applications (2)

Application Number Title Priority Date Filing Date
ES00102413T Expired - Lifetime ES2277581T3 (es) 1993-03-12 1994-03-11 Proteinas y peptidos alergenos de acaros del polvo domestico y usos de los mismos.
ES94910283T Expired - Lifetime ES2150986T3 (es) 1993-03-12 1994-03-11 Proteina y peptidos alergenicos de los acaros del polvo domestico y aplicaciones para los mismos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES00102413T Expired - Lifetime ES2277581T3 (es) 1993-03-12 1994-03-11 Proteinas y peptidos alergenos de acaros del polvo domestico y usos de los mismos.

Country Status (14)

Country Link
US (5) US6849427B1 (es)
EP (2) EP1018550B1 (es)
JP (3) JP3742426B2 (es)
AT (2) ATE195343T1 (es)
AU (1) AU690900B2 (es)
CA (1) CA2158047C (es)
DE (2) DE69434885T2 (es)
DK (2) DK0690914T3 (es)
ES (2) ES2277581T3 (es)
IL (2) IL108921A (es)
NZ (1) NZ262860A (es)
PT (2) PT1018550E (es)
WO (1) WO1994020614A1 (es)
ZA (1) ZA941713B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6849427B1 (en) * 1993-03-12 2005-02-01 Immulogic Pharmaceutical Corp. Nucleic acids encoding a house dust mite allergen, Der p VII, and uses therefor
EP0873135B1 (en) * 1995-12-29 2009-07-22 The University of Arkansas Peanut allergens and methods
EP1015565B1 (en) 1997-09-19 2006-04-12 Metabolix, Inc. Biological systems for manufacture of polyhydroxyalkanoate polymers containing 4-hydroxyacids
AU743647B2 (en) 1998-01-31 2002-01-31 Mt. Sinai School Of Medicine Of New York University Methods and reagents for decreasing allergic reactions
US7879977B2 (en) 1998-01-31 2011-02-01 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
US7439233B1 (en) * 1999-02-25 2008-10-21 Tai June Yoo Vaccine for house dust mite allergen using naked DNA
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
AU1951001A (en) 2000-04-06 2001-09-17 Panacea Pharm Llc Microbial delivery system
US8246945B2 (en) 2000-04-06 2012-08-21 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
US20020168782A1 (en) * 2001-01-03 2002-11-14 Mccall Catherine A. Detection of allergen-specific IgE
US7060687B2 (en) 2001-02-07 2006-06-13 Genmont Biotechnology Co. Live vaccines for allergy treatment
GB0120150D0 (en) * 2001-08-17 2001-10-10 Glaxosmithkline Biolog Sa Novel compounds
US20060251667A1 (en) * 2002-08-29 2006-11-09 Chua Kaw Y Recombinant nucleic acid useful for inducing protective immune response against allergens
JP4043387B2 (ja) * 2003-03-18 2008-02-06 三菱重工業株式会社 空調用室内ユニット及びこれを備えた空気調和機
WO2005100995A2 (en) * 2004-04-06 2005-10-27 Mount Sinai School Of Medicine Methods of determining allergen response using microarray imminoassay techinques
US20060269576A1 (en) * 2005-05-27 2006-11-30 Curalogic, A/S Non-injection immunotherapy
CN101784655A (zh) * 2007-04-27 2010-07-21 菲尼克斯股份有限公司 可溶性重组二十面体病毒样颗粒的改良生成和体内装配
NZ583362A (en) * 2007-08-15 2012-06-29 Circassia Ltd Peptide with reduced dimer formation
US8859210B2 (en) * 2008-10-17 2014-10-14 Mead Johnson Nutrition Company Method for identifying allergenic proteins and peptides
JP2018183105A (ja) * 2017-04-27 2018-11-22 日光ケミカルズ株式会社 皮膚刺激評価方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4745051A (en) * 1983-05-27 1988-05-17 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
US4879213A (en) * 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
PT87133B (pt) * 1987-04-02 1992-07-31 Amrad Corp Ltd Metodo de purificacao do factor inibidor da leucemia (lif) e de composicoes farmaceuticas contendo polipeptidos com actividade do lif
US5077214A (en) * 1989-07-07 1991-12-31 The Texas A&M University System Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells
JP3139777B2 (ja) 1990-08-27 2001-03-05 フマキラー株式会社 組換えダニアレルゲン
US6849427B1 (en) * 1993-03-12 2005-02-01 Immulogic Pharmaceutical Corp. Nucleic acids encoding a house dust mite allergen, Der p VII, and uses therefor

Also Published As

Publication number Publication date
ZA941713B (en) 1994-10-26
JP2007151555A (ja) 2007-06-21
US20020168373A1 (en) 2002-11-14
DE69434885D1 (de) 2007-01-04
US8003382B2 (en) 2011-08-23
DE69434885T2 (de) 2007-12-06
DK1018550T3 (da) 2007-04-02
US6849427B1 (en) 2005-02-01
JP3742426B2 (ja) 2006-02-01
CA2158047C (en) 2010-06-08
NZ262860A (en) 1997-08-22
EP0690914A1 (en) 1996-01-10
US6413738B1 (en) 2002-07-02
ES2277581T3 (es) 2007-07-16
EP1018550A2 (en) 2000-07-12
EP1018550B1 (en) 2006-11-22
JP3934594B2 (ja) 2007-06-20
CA2158047A1 (en) 1994-09-15
IL108921A0 (en) 1994-06-24
US20050260218A1 (en) 2005-11-24
JP2004113249A (ja) 2004-04-15
JPH09501042A (ja) 1997-02-04
IL149905A0 (en) 2002-11-10
US6077517A (en) 2000-06-20
AU690900B2 (en) 1998-05-07
DE69425490T2 (de) 2001-04-19
PT1018550E (pt) 2007-02-28
AU6278394A (en) 1994-09-26
EP0690914A4 (en) 1997-05-21
PT690914E (pt) 2001-01-31
ATE195343T1 (de) 2000-08-15
EP0690914B1 (en) 2000-08-09
WO1994020614A1 (en) 1994-09-15
ATE346149T1 (de) 2006-12-15
DE69425490D1 (de) 2000-09-14
EP1018550A3 (en) 2000-10-11
DK0690914T3 (da) 2000-10-02
IL108921A (en) 2006-04-10
US6905845B2 (en) 2005-06-14

Similar Documents

Publication Publication Date Title
ES2150986T3 (es) Proteina y peptidos alergenicos de los acaros del polvo domestico y aplicaciones para los mismos.
CA2144055A1 (en) Cloning and Sequencing of Allergens of Dermatophagoides (House Dust Mite)
ATE178940T1 (de) Klonierung und sequenzierung von dermatophagoiden-antigenen (hausstaubmilben)
NO941371L (no) T-celle-epitoper av hovedallergener av Dermatophagoides (hus-stöv-midd)
Van Hofsten et al. Molecular cloning, cDNA sequencing, and chemical synthesis of cecropin B from Hyalophora cecropia.
EP0456152B1 (de) Peptidamide, Verfahren zu deren Herstellung und diese enthaltende Mittel als Fibrin/Thrombin-Gerinnungsinhibitoren
DE69333985D1 (de) Allergene proteine und peptide von hundhautanhangsgebilden und ihre verwendung
ATE102956T1 (de) Polypeptide und deren derivate und deren verwendung in pharmazeutischen und diagnostischen zusammensetzungen.
PL165148B1 (en) Method of obtaining polyamines and polypeptides
NO962407L (no) Nukleinsyrer som koder for et husstöv-midd-allergen, DER P III og bruk derav
Wellman et al. Secondary structure of synthetic peptides derived from the repeating unit of a giant secretory protein from Chironomus tentans
ATE120800T1 (de) Antigen-protein der sporozoit- und hepatischen phase von p. falciparum.
DK0635027T3 (da) Peptid T og beslægtede peptider til behandling af inflammation, herunder dissemineret sclerose
CA2160121A1 (en) T cell epitopes of the major allergens from dermatophagoides (house dust mite)
Case Secondary structure of synthetic peptides derived from the repeating unit of a giant secretory protein
Kubiak et al. Probing SAR of FLRF-NH2 with its N-and C-terminally modified analogs and retro-inverso peptides
Sugiyama et al. The amino acid sequence of a salivary peptide (FA) with histamine-releasing property
RU2020141729A (ru) Лечение и профилактика аллергии на клещей домашней пыли
ES2051152B1 (es) Procedimiento de sistesis de peptidos con capacidad de detectar anticuerpos anti-virus de la hepatitis c (vhc) en suero de individuos afectados.
TH14326A (th) โปรตีเอสและสารประกอบดีเอนเอที่เกี่ยวข้อง
TH4141A (th) สารคล้ายคลึง จีอาร์เอฟ (grf)

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 690914

Country of ref document: ES